In the IASP 2021 Virtual World Congress of Pain, the results from Orion Corporation’s pilot study ‘VIRPI’ were announced. The novel treatment, a digital therapeutics software solution for Chronic Pain, “DTxP”, has shown statistically significant benefit over passive (placebo) control and standard care interventions for fear of movement, patient clinical global impression of change (PGIC) and quality of life in adult patients with chronic low back pain (CLBP).
The DTxP software has been developed by Orion in close collaboration with external scientific advisor Christopher Eccleston from University of Bath, and technology partner Healthware Group, with support from Business Finland.
Earlier when the results were announced, Sammeli Liikkanen, Director of Digital Medicine at Orion Corporation, noted how Digital therapeutics (DTx) is a new and rapidly evolving treatment paradigm, also for pain.
This year at the Frontiers Health 2021, which takes place in November 11 – 12, Mr. Liikkanen and Mr. Eccleston are joined on stage by Kati Kaijasilta, Business Development Director at Orion Corporation as well as Petteri Kolehmainen, Managing Director for Nordics and Baltics at Healthware Group.
In this session, you’ll learn more about chronic pain and how it has been treated with Behavioral Cognitive Therapy, hear the compelling story how the DTxP solution was developed and obtain more details about the results of the VIRPI study. You’ll see actual video from the virtual reality experience from the study, as well as a glimpse into the next version of the solution, which is currently under development. The session will end with introductions to the business and partnership opportunities, as well as taking questions from the audience.
Frontiers Health is one of the premier global digital health innovation events, with a strong focus on digital therapies, breakthrough technologies, healthcare transformation, investments, and ecosystem development. This year it is held in Milan, Italy, and virtually on November 11th and 12th.